Bankwell Financial Director Lawrence B. Seidman reports purchase of 2,540 common shares worth $167,400.12
Reuters2026/08/26 15:21- Director Lawrence B. Seidman reported purchases of Bankwell Financial common stock through affiliated investment vehicles.
- Total acquired: 2,540 shares at prices around $65.89 to $66.01.
- Largest post-transaction holdings included 223,684 shares held by Seidman and Associates, 178,352 by Seidman Investment Partnership II.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cambria Gold Mines FY26 Q2 net loss narrows to CAD 2.96 million
TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
Crypto prices
More
